🔎 Trials Near Me

መነሻ › የክሮን በሽታ › Rhode Island › Providence

በProvidence፣ RI ለየክሮን በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች

ለየክሮን በሽታ የሚደረጉ 12 ጥናቶች በProvidence እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University Gastroenterology - Providence - West River Street ( Site 5057), Providence
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06430801

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • University Gastroenterology, Providence
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06581328

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • University Gastroenterology, Providence
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07196722

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University Gastroenterology Providence, Providence
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06233461

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University Gastroenterology, Providence
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University Gastroenterology-Site Number: 8400103, Providence
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07184931

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University Gastroenterology - GI Alliance-Site Number: 8400103, Providence
እድሜ ከ16 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07184944

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • University Gastroenterology, Providence
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

ተሳታዮችን በመፈለግ ላይ
  • Gastroenterology Associates, Providence
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኦገስ 2026 · NCT05230173

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • Rhode Island Hospital, Providence
እድሜ ከ6 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ27 ሜይ 2026 · NCT05781152

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mirador Therapeutics Selected Site, Providence
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ12 ማርች 2026 · NCT07113522

በሌሎች ከተሞች ለየክሮን በሽታ የሚደረጉ ጥናቶች

በProvidence ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።